Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
3(38%)
Results Posted
100%(2 trials)
Terminated
3(38%)

Phase Distribution

Ph phase_2
1
13%
Ph not_applicable
2
25%
Ph phase_1
1
13%
Ph early_phase_1
4
50%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
4(50.0%)
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(2)
Terminated(3)

Detailed Status

Terminated3
Completed2
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
40.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 14 (50.0%)
Phase 11 (12.5%)
Phase 21 (12.5%)
N/A2 (25.0%)

Trials by Status

active_not_recruiting113%
completed225%
recruiting225%
terminated338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8